In- and out-licensing evaluation
We help you to identify, qualify, and prioritize possible in- and out-licensing evaluation candidates and evaluate their commercial potential. With substantial capabilities including rapid assessment and comprehensive due diligence, we can provide information and guidance across each phase of your engagement.
In- and out-licensing evaluation
A diverse team with a proven track record
Our clinical, epidemiology, access, and forecasting experts work collaboratively to support holistic and comprehensive in- and out-licensing evaluations, ensuring confident decision-making.
We can support you as part of a long-term strategic process or as tactical support at critical points that may require an independent validation.
Drawing on trusted data sources
We draw upon data sources such as the Oracle Life Sciences Epi Database, Oracle Life Sciences CancerMPact, and Oracle EHR Real-World Data, plus vital medical literature, government databases, and patient surveys. Our experts can deliver accurate, holistic insights into market trends to inform your decisions regarding in- and out-licensing opportunities.
Licensing evaluation for diverse commercial applications
Our experts work across disciplines to support your decision-making around licensing options, enabling you to
- Assess the overall landscape, competitive market, and market access
- Quantify the clinical and commercial value of your products
- Identify and validate partnership or acquisition opportunities
- Conduct commercial and scientific due diligence
- Forecast revenue, analyze cash flow, and value assets
- Map opportunities to organizational strategy and goals
Oracle Life Sciences 入門
聯絡我們
與 Oracle 團隊成員討論我們的生命科學解決方案。
關注我們的播客
聆聽來自製藥、生物技術和 CRO 的科學家、臨床醫生及業界領袖的分享，瞭解他們如何推動生命科學和健康領域的創新。
取得技術支援
瞭解技術支援聯絡人和資源。